von willebrand factor human

Poland

Drugs containing this active substance

  • HAEMATE P 1000 UNITS FVIII/2400 UNITS VWF

    The medicinal product is used for the prophylaxis and treatment of bleeding caused by a deficiency of von Willebrand factor (von Willebrand disease) or a deficiency of factor VIII (haemophilia A). It may also be used in the therapy of acquired factor VIII deficiency and in patients with antibodies against it.

    Form: solution for injection or infusion, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 1000 j.m.
    von willebrand factor human 2400 j.m.

    ATC: B02BD06

    Manufacturer: CSL Behring GmbH

  • HAEMATE P 250 J.M. FVIII/600 J.M. VWF

    The medicinal product is used for the prophylaxis and treatment of bleeding in individuals with von Willebrand disease and in haemophilia A (factor VIII deficiency). It may also be used in the therapy of acquired factor VIII deficiency and in patients possessing antibodies against this factor.

    Form: solution for injection or infusion, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 250 j.m.
    von willebrand factor human 600 j.m.

    ATC: B02BD06

    Manufacturer: CSL Behring GmbH

  • HAEMATE P 500 U. FVIII/1200 U. VWF

    The medicinal product is used for the prophylaxis and treatment of bleeding caused by a deficiency of von Willebrand factor (von Willebrand disease) or a deficiency of factor VIII (haemophilia A). It may also be used in the treatment of acquired factor VIII deficiency and in patients with antibodies against it.

    Form: solution for injection or infusion, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 500 j.m.
    von willebrand factor human 1200 j.m.

    ATC: B02BD06

    Manufacturer: CSL Behring GmbH

  • IMMUNATE 1000 IU FVIII/750 IU VWF

    The medicinal product is used for the treatment and prevention of bleeding in congenital (haemophilia A) or acquired factor VIII deficiency. It may also be used for the treatment of bleeding in patients with von Willebrand disease if other methods are ineffective or contraindicated.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 100 j.m./ml
    von willebrand factor human 75 j.m./ml

    ATC: B02BD02

    Manufacturer: Takeda Manufacturing Austria AG

  • IMMUNATE 250 IU FVIII/190 IU VWF

    The medicinal product is used for the treatment and prevention of bleeding in congenital (haemophilia A) or acquired factor VIII deficiency. It is also used for the treatment of bleeding in patients with von Willebrand disease if other methods are ineffective or contraindicated.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 50 j.m./ml
    von willebrand factor human 38 j.m./ml

    ATC: B02BD02

    Manufacturer: Takeda Manufacturing Austria AG

  • IMMUNATE 500 IU FVIII/375 IU VWF

    The medicinal product is used for the treatment and prevention of bleeding in congenital (haemophilia A) or acquired factor VIII deficiency. It may also be used for the treatment of bleeding in patients with von Willebrand disease if other treatment methods are ineffective or contraindicated.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 100 j.m./ml
    von willebrand factor human 75 j.m./ml

    ATC: B02BD02

    Manufacturer: Takeda Manufacturing Austria AG

  • WILATE 1000

    Wilate is used for the treatment and prevention of bleeding in individuals suffering from von Willebrand disease and in patients with haemophilia A.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 1000 j.m.
    von willebrand factor human 1000 j.m.

    ATC: B02BD06

    Manufacturer: Octapharma GmbH

  • WILATE 500

    Wilate is used for the treatment and prevention of bleeding in individuals suffering from von Willebrand disease and in patients with haemophilia A.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human coagulation factor viii 500 j.m.
    von willebrand factor human 500 j.m.

    ATC: B02BD06

    Manufacturer: Octapharma GmbH

  • WILLFACT 1000 J.M.

    The medicine is used to prevent bleeding related to surgical procedures and to treat bleeding in individuals with von Willebrand disease (if other treatment methods are ineffective or contraindicated).

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    von willebrand factor human 1000 j.m.

    ATC: B02BD10

    Manufacturer: LFB-Biomedicaments

  • WILLFACT 2000 J.M.

    The medicine is used to prevent bleeding related to surgical procedures and to treat bleeding in individuals with von Willebrand disease (if other methods are ineffective or contraindicated).

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    von willebrand factor human 2000 j.m.

    ATC: B02BD10

    Manufacturer: LFB-Biomedicaments

  • WILLFACT 500 J.M.

    The medicine is used to prevent bleeding related to surgical procedures and to treat bleeding in individuals with von Willebrand disease (if other methods are ineffective or contraindicated).

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    von willebrand factor human 500 j.m.

    ATC: B02BD10

    Manufacturer: LFB-Biomedicaments